Mirsaeedi-Farahani Keyvan has reported a transaction involving 12,770 shares of Adagio Medical Holdings, Inc. This event is significant as it showcases Keyvan's ongoing involvement in the company as a director. The transaction was filed on October 13, 2026, and reflects a pro rata distribution of common stock.
Adagio Medical Holdings, Inc. operates within the surgical and medical instruments industry, providing essential products and services. The company has been navigating changes since its name change from Aja Holdco, Inc. on January 4, 2024. The recent filing, accession number 0002031256-26-000004, highlights the continued engagement of its directors in the company’s operations.
The filing states that the transaction occurred on September 27, 2024, under the code 'A', indicating an acquisition of shares. Keyvan now owns a total of 12,770 shares following this transaction. The filing notes that this acquisition was a pro rata distribution of common stock for no consideration.
This update may affect shareholders and other stakeholders in Adagio Medical Holdings, as it reflects the company's ongoing adjustments and the active participation of its directors in managing their equity positions. The surgical and medical instruments industry continues to evolve, and such transactions can impact investor perceptions and company strategy.
Details were not available in the SEC filing regarding any future actions or implications stemming from this transaction.